ESCO (ESE) Q2 2026 Earnings Call Transcript

ESCO Technologies posted a strong Q2, with orders up 42%, sales up 33.5%, adjusted EBIT margins expanding 370 bps to 21.7%, and adjusted EPS rising 63% to $1.91. Management raised full-year 2026 adjusted EPS guidance to $8.00-$8.25, cited record backlog, and said the Megger acquisition remains on track for a Q1 FY2027 closing. Offsetting the strength, NRG remains weak due to renewables policy headwinds and Maritime sales are tracking toward the low end of guidance.

Analysis

This is less a one-quarter story than a multi-year mix-shift inflection: the company is using defense/naval backlog, utility grid modernization, and test/EMC demand to offset the cyclicality of renewables. The important second-order effect is pricing power: once utilities are allowed to capitalize condition-monitoring equipment into rate base, the buying decision shifts from budget scrutiny to regulated ROI, which should lift duration of demand and compress replacement cycles across the installed base. That tends to favor the higher-quality instrumentation players and weakens price competition because the customer is now optimizing reliability and regulatory compliance, not just capex.

The biggest hidden positive is balance-sheet optionality. Low leverage plus strong cash conversion ahead of a large acquisition means the company can finance Megger without forcing equity dilution or a near-term balance-sheet reset, and the acquisition timing creates a clean catalyst sequence: close in early FY27, then synergy realization and accretion follow in FY27-FY28. The market may still be underestimating how quickly the Test segment can re-rate if management’s margin ambition is pulled forward; that is the highest operating leverage bucket and the cleanest path to multiple expansion if organic growth stays in the mid-single digits and margins approach 20% sooner than expected.

The main risk is that the current mix is flattering margins at exactly the wrong time: renewables softness can persist longer than investors expect, and maritime slippage suggests some defense revenue is timing-shifted rather than lost. In the next 1-2 quarters, the stock can be vulnerable if investors focus on the guide staying flat despite stronger Test demand, because that implies other segments are masking momentum rather than confirming it. Over 12-18 months, the real swing factor is whether Megger integration is a clean add-on or becomes a distraction that delays the utility platform payoff.

Key Decisions for Investors

• Long ESE on pullbacks over the next 2-6 weeks; use weakness tied to unchanged revenue guide as entry. Risk/reward favors owning the cash-flow compounding story with a 12-month target driven by FY27 Megger accretion and margin expansion.
• Relative-value pair: long ESE / short NRG for the next 3-6 months. The market is rewarding grid modernization while penalizing policy-sensitive renewables; this isolates the utility capex winner from the renewable winner-to-loser transition.
• Add to ESE only if Test segment commentary continues to point toward 20% EBITDA margins and 4%-6% organic growth. That combination is the strongest catalyst for multiple expansion over the next 2-4 quarters.
• Use any rally in NRG into policy relief headlines to fade strength via put spreads or outright short. The setup is a slow-demand recovery at best, with margin pressure persisting while developers keep reacting to tax-credit sunsets.
• For event-driven accounts, consider a call spread in ESE into the next 6-9 months to capture Megger-related rerating while capping premium outlay. Best payoff occurs if close timing stays on track and management confirms synergy capture before FY27.